Log in

NYSE:XANExantas Capital Stock Price, Forecast & News

$2.31
-0.10 (-4.15 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.26
Now: $2.31
$2.51
50-Day Range
$2.00
MA: $2.56
$4.42
52-Week Range
$0.95
Now: $2.31
$12.51
Volume1.49 million shs
Average Volume1.35 million shs
Market Capitalization$74.02 million
P/E RatioN/A
Dividend YieldN/A
Beta1.41
Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial mortgage loans and commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments related to commercial real estate (CRE), commercial mortgage-backed securities, and CRE equity investments. The company qualifies as a real estate investment trust (REIT) for federal income tax purposes. It generally would not be subject to federal corporate income tax to the extent that it distributes 100% of its REIT taxable income. The company was formerly known as Resource Capital Corp. and changed its name to Exantas Capital Corp. in May 2018. Exantas Capital Corp. was founded in 2005 and is based in New York, New York.
Read More
Exantas Capital logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.48 out of 5 stars


Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
CUSIPN/A
CIKN/A
Phone212-621-3210

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$61.15 million
Cash Flow$1.44 per share
Book Value$17.45 per share

Profitability

Net Income$35.97 million
Net Margins-274.26%

Miscellaneous

EmployeesN/A
Market Cap$74.02 million
Next Earnings Date7/29/2020 (Estimated)
OptionableOptionable

Receive XAN News and Ratings via Email

Sign-up to receive the latest news and ratings for XAN and its competitors with MarketBeat's FREE daily newsletter.

Exantas Capital (NYSE:XAN) Frequently Asked Questions

How has Exantas Capital's stock been impacted by COVID-19 (Coronavirus)?

Exantas Capital's stock was trading at $9.75 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, XAN stock has decreased by 76.3% and is now trading at $2.31. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Exantas Capital?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exantas Capital in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Exantas Capital.

When is Exantas Capital's next earnings date?

Exantas Capital is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Exantas Capital.

How were Exantas Capital's earnings last quarter?

Exantas Capital Corp (NYSE:XAN) announced its earnings results on Thursday, May, 7th. The company reported $0.23 EPS for the quarter, missing the consensus estimate of $0.30 by $0.07. The company earned $14.90 million during the quarter. Exantas Capital had a positive return on equity of 7.95% and a negative net margin of 274.26%. View Exantas Capital's earnings history.

How often does Exantas Capital pay dividends? What is the dividend yield for Exantas Capital?

Exantas Capital announced a quarterly dividend on Friday, March 13th. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.275 per share on Tuesday, April 28th. This represents a $1.10 annualized dividend and a dividend yield of 47.62%. The ex-dividend date of this dividend is Monday, March 30th. View Exantas Capital's dividend history.

What price target have analysts set for XAN?

2 Wall Street analysts have issued twelve-month target prices for Exantas Capital's shares. Their forecasts range from $4.00 to $4.00. On average, they expect Exantas Capital's share price to reach $4.00 in the next twelve months. This suggests a possible upside of 73.2% from the stock's current price. View analysts' price targets for Exantas Capital.

Has Exantas Capital been receiving favorable news coverage?

News coverage about XAN stock has trended negative this week, InfoTrie reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Exantas Capital earned a news sentiment score of -2.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about Exantas Capital.

Are investors shorting Exantas Capital?

Exantas Capital saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 3,050,000 shares, a drop of 16.4% from the June 15th total of 3,650,000 shares. Based on an average daily trading volume, of 2,230,000 shares, the days-to-cover ratio is presently 1.4 days. Currently, 9.8% of the company's shares are sold short. View Exantas Capital's Current Options Chain.

Who are some of Exantas Capital's key competitors?

What other stocks do shareholders of Exantas Capital own?

Who are Exantas Capital's key executives?

Exantas Capital's management team includes the following people:
  • Mr. Robert C. Lieber, Chief Exec. Officer (Age 65)
  • Mr. Matthew J. Stern, Pres (Age 45)
  • Mr. David J. Bryant, Sr. VP, CFO & Treasurer (Age 61)
  • Mr. Thomas C. Elliott, Exec. VP of Fin. & Operations (Age 46)
  • Mr. Eldron C. Blackwell, VP & Chief Accounting Officer (Age 40)

What is Exantas Capital's stock symbol?

Exantas Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "XAN."

How do I buy shares of Exantas Capital?

Shares of XAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Exantas Capital's stock price today?

One share of XAN stock can currently be purchased for approximately $2.31.

How big of a company is Exantas Capital?

Exantas Capital has a market capitalization of $74.02 million and generates $61.15 million in revenue each year. The company earns $35.97 million in net income (profit) each year or $1.00 on an earnings per share basis.

What is Exantas Capital's official website?

The official website for Exantas Capital is www.exantas.com.

How can I contact Exantas Capital?

Exantas Capital's mailing address is 717 FIFTH AVENUE, NEW YORK NY, 10022. The company can be reached via phone at 212-621-3210 or via email at [email protected]

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.